| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medicine (Gastroenterology Division) [R. F. B., J. Y., T. M., S. J. M.], Microbiology and Immunology [Y. H.], Pathology [C. N., J. H. R., S. J. M.], Graduate Program in Molecular and Cell Biology [T. M., S. J. M.], and Cancer Center [S. J. M.], University of Maryland and Department of Veterans Affairs Hospital, Baltimore, Maryland 21201; and Gastroenterology Division [P. L. B., B. J. R.], and Departments of Medicine [P. L. B., B. J. R., W. H. R.], and Pathology [R. C. H.], University of Washington, Seattle, Washington 98195
Abnormalities in the retinoblastoma tumor suppressor gene (Rb) have been observed in a large number of human cancers. Loss of heterozygosity is a common mode of allelic inactivation of Rb and other tumor suppressor genes. We investigated DNA from 61 primary human esophageal tumors for loss of heterozygosity at the Rb locus using a polymerase chain reaction-based restriction fragment length polymorphism assay. Of informative cases, we found loss of heterozygosity in 14 of 26 (54%) squamous cell carcinomas and 5 of 14 (36%) adenocarcinomas. These data support the hypothesis that Rb inactivation is involved in the pathogenesis and/or progression of esophageal cancer.
1 This work was supported by American Cancer Society Grants PDT-419 and PDT-316B, the Lyn P. Meyerhoff Memorial Research Grant from the Crohn's and Colitis Foundation of America, the Frank C. Bressler Research Fund, the University of Maryland Department of Medicine Research Initiative Fund, NIH Grant P01 DK32971, and the Department of Veterans Affairs.
2 To whom requests for reprints should be addressed, at University of Maryland Hospital, Department of Medicine/GI, N3W62, 22 South Greene Street, Baltimore, MD 21201.
Received 7/24/91. Accepted 8/29/91.
This article has been cited by other articles:
![]() |
J. M.Y. Ko, P. L. Chan, W. L. Yau, H. K. Chan, K. C. Chan, Z. Y. Yu, F. M. Kwong, L. D. Miller, E. T. Liu, L. C. Yang, et al. Monochromosome Transfer and Microarray Analysis Identify a Critical Tumor-Suppressive Region Mapping to Chromosome 13q14 and THSD1 in Esophageal Carcinoma Mol. Cancer Res., April 1, 2008; 6(4): 592 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Muirhead, H T Hoffman, and R A Robinson Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma J. Clin. Pathol., July 1, 2006; 59(7): 711 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tong, Y. Zhong, J. Kong, L. Dong, Y. Song, M. Fu, Z. Liu, M. Wang, L. Guo, S. Lu, et al. Overexpression of Aurora-A Contributes to Malignant Development of Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., November 1, 2004; 10(21): 7304 - 7310. [Abstract] [Full Text] [PDF] |
||||
![]() |
C P Morales, K G Gandia, R D Ramirez, W E Wright, J W Shay, and S J Spechler Characterisation of telomerase immortalised normal human oesophageal squamous cells Gut, March 1, 2003; 52(3): 327 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sato, N. Harpaz, D. Shibata, Y. Xu, J. Yin, Y. Mori, T.-T. Zou, S. Wang, K. Desai, A. Leytin, et al. Hypermethylation of the p14ARF Gene in Ulcerative Colitis-associated Colorectal Carcinogenesis Cancer Res., February 1, 2002; 62(4): 1148 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, N. Hu, A. M. Goldstein, M. R. Emmert-Buck, Z.-Z. Tang, M. J. Roth, Q.-H. Wang, S. M. Dawsey, X.-Y. Han, T. Ding, et al. High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China Carcinogenesis, November 1, 2000; 21(11): 2019 - 2026. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikeguchi, S. Oka, Y. Gomyo, S. Tsujitani, M. Maeta, and N. Kaibara Combined analysis of p53 and retinoblastoma protein expressions in esophageal cancer Ann. Thorac. Surg., September 1, 2000; 70(3): 913 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Harada, H. Tanaka, Y. Shimada, M. Shinoda, M. Imamura, and K. Ishizaki Lymph Node Metastasis Is Associated with Allelic Loss on Chromosome 13q12-13 in Esophageal Squamous Cell Carcinoma1 Cancer Res., August 1, 1999; 59(15): 3724 - 3729. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Xing, G.-Y. Yang, L.-D. Wang, S. T. Shi, and C. S. Yang Loss of Heterozygosity of the Rb Gene Correlates with pRb Protein Expression and Associates with p53 Alteration in Human Esophageal Cancer Clin. Cancer Res., May 1, 1999; 5(5): 1231 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Du Plessis, E. Dietzsch, M. Van Gele, N. Van Roy, P. Van Helden, M. I. Parker, D. K. Mugwanya, M. De Groot, M. P. Marx, M. J. Kotze, et al. Mapping of Novel Regions of DNA Gain and Loss by Comparative Genomic Hybridization in Esophageal Carcinoma in the Black and Colored Populations of South Africa Cancer Res., April 1, 1999; 59(8): 1877 - 1883. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |